Edie Renee Hapner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Edie Renee Hapner has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
Michael M. Johns
USC Voice Center, USC Caruso Department of Otolaryngology - Head and Neck Surgery, Keck Medicine of USC, Los Angeles, California
16 shared publicationsJustin C. Wise
7 shared publicationsAdam M. Klein
The Emory Voice Center, Department of Otolaryngology, Emory University, Atlanta, Georgia
6 shared publications- Michael M. Johns
Emory Voice Center, Department of Otolaryngology-Head and Neck Surgery, Emory University School of Medicine, Atlanta, Georgia
5 shared publications Laura J. White
4 shared publicationsAdam Klein
3 shared publications
Latest Publications
- 1 May 2024
- Published by Elsevier in Journal of Voice
- Vol. 38 (3) , 666-673
The Voice Problem Impact Scales (VPIS)
- 1 May 2024
- Published by Elsevier in Journal of Voice
- Vol. 38 (3) , 666-673
The Voice Problem Impact Scales (VPIS)
- 1 May 2024
- Published by Elsevier in Journal of Voice
- Vol. 38 (3) , 723-730
Laryngologists’ Reported Decision-Making in Presbyphonia Treatment
- 1 May 2024
- Published by Elsevier in Journal of Voice
- Vol. 38 (3) , 723-730
Laryngologists’ Reported Decision-Making in Presbyphonia Treatment
- 29 November 2023
- Published by Elsevier in Journal of Voice
- Vol. 40 (3) , 667-672
Reliability of Phonemically Loaded Sentences in Spanish for Identifying Laryngeal Dystonia by Non-Spanish Speaking Speech-Language Pathologists
- 29 November 2023
- Published by Elsevier in Journal of Voice
- Vol. 40 (3) , 667-672
Reliability of Phonemically Loaded Sentences in Spanish for Identifying Laryngeal Dystonia by Non-Spanish Speaking Speech-Language Pathologists
- 11 March 2023
- Published by Elsevier in Journal of Voice
- Vol. 39 (4) , 921-927
Membranous Vocal Fold Lesions in Patients With Chronic Cough: A Case Series
- 11 March 2023
- Published by Elsevier in Journal of Voice
- Vol. 39 (4) , 921-927
Membranous Vocal Fold Lesions in Patients With Chronic Cough: A Case Series
- 1 March 2023
- Published by Elsevier in Journal of Voice
- Vol. 37 (2) , 297.e7-297.e13
The Impact of Referral Source on Voice Therapy
- 1 March 2023
- Published by Elsevier in Journal of Voice
- Vol. 37 (2) , 297.e7-297.e13
The Impact of Referral Source on Voice Therapy
- 1 March 2023
- Published by Elsevier in Journal of Voice
- Vol. 37 (2) , 290.e1-290.e6
VHI-10 Scores in a Treatment-Seeking Population With Dysphonia
- 1 March 2023
- Published by Elsevier in Journal of Voice
- Vol. 37 (2) , 290.e1-290.e6
VHI-10 Scores in a Treatment-Seeking Population With Dysphonia
- 21 June 2022
- Published by American Speech Language Hearing Association in Perspectives of the Asha Special Interest Groups
- p. 1-6
Considerations for Specialty Education in Voice and Upper Airway Disorders
Purpose: The purpose of this article was to describe the development and contributions of a voice and upper airway disorders (VUAD) grassroots committee of experts toward defining core features of a VUAD-focused clinical fellowship (CF). This group grew over 3 years to include more than 35 clinical experts representing multiple VUAD clinic sites across varied regions of the United States. This group proposed entry- and exit-level knowledge and skills and expectations for successful VUAD CF training outcomes at the 2021 American Speech-Language-Hearing Association Convention. In addition, this group formulated resources and educational support networks for VUAD CF trainees and their supervisors. Future work by this group will define the criteria by which VUAD CFs will be included as part of clinical expertise experiences evaluated by the VUAD board. Conclusions: A collaborative group of grassroots experts in VUAD defined core entry- and exit-level expectations for clinical competency upon completion of a VUAD CF. Future research and efforts by this group will further characterize the current VUAD CF settings, populations served, and ranges of assessment and treatment services provided. Pilot programs were conducted offering educational and supervisory resources with positive outcomes that endorse the need for these critical mechanisms for supporting VUAD trainees and colleagues.
- 21 June 2022
- Published by American Speech Language Hearing Association in Perspectives of the Asha Special Interest Groups
- p. 1-6
Considerations for Specialty Education in Voice and Upper Airway Disorders
Purpose: The purpose of this article was to describe the development and contributions of a voice and upper airway disorders (VUAD) grassroots committee of experts toward defining core features of a VUAD-focused clinical fellowship (CF). This group grew over 3 years to include more than 35 clinical experts representing multiple VUAD clinic sites across varied regions of the United States. This group proposed entry- and exit-level knowledge and skills and expectations for successful VUAD CF training outcomes at the 2021 American Speech-Language-Hearing Association Convention. In addition, this group formulated resources and educational support networks for VUAD CF trainees and their supervisors. Future work by this group will define the criteria by which VUAD CFs will be included as part of clinical expertise experiences evaluated by the VUAD board. Conclusions: A collaborative group of grassroots experts in VUAD defined core entry- and exit-level expectations for clinical competency upon completion of a VUAD CF. Future research and efforts by this group will further characterize the current VUAD CF settings, populations served, and ranges of assessment and treatment services provided. Pilot programs were conducted offering educational and supervisory resources with positive outcomes that endorse the need for these critical mechanisms for supporting VUAD trainees and colleagues.
- 1 September 2016
- Published by Elsevier in Journal of Voice
- Vol. 30 (5) , 563-573
The Development of Conversation Training Therapy: A Concept Paper
- 1 September 2016
- Published by Elsevier in Journal of Voice
- Vol. 30 (5) , 563-573
The Development of Conversation Training Therapy: A Concept Paper
- 4 December 2014
- Published by Wiley in The Laryngoscope
- Vol. 125 (5) , 1149-1154
Safety and efficacy of multiuse botulinum toxin vials for intralaryngeal injection
Objectives/Hypothesis: Centers for Disease Control and Prevention guidelines maintain that single‐use vials cannot be used for multiple patients. Botox product labeling states that the reconstituted toxin should be used within 4 hours on a single patient based on concerns of reduced potency, contamination, and consequent infections. The purpose of this study was to determine the safety and efficacy of using single‐use vials in a multidose fashion.Study Design: Prospective study and cohort chart review.Methods: A multi‐institutional three‐part study was performed between May 2013 and October 2013: 1) a summation of subjects' recall of their past experiences (symptoms/response) with previous multidose Botox injections, 2) a prospective study of intralaryngeal injections, and 3) a chart review of injection responses in a subset of the cohort.Results: Seven hundred forty‐three subjects receiving 6,216 injections demonstrated zero infection‐related complications on retrospective chart review. One hundred seventy‐nine subjects recalled 24.0% overall adverse events, 10.6% redness, 7.3% pain and swelling at the injection site, and 0% fever. One hundred seventy‐four subjects prospectively reported 12.6% overall adverse events. The self‐reported efficacy rate of Botox injection was 96.6%.Conclusions: The low rates of adverse events following the use of Botox in a multipatient fashion are consistent with other percutaneous injections. No evidence of infection was found with multidose Botox use. Given the low incidence of side effects and high success rate, Botox can be used both safely and effectively in a multipatient fashion.Level of Evidence: 4 Laryngoscope, 125:1149–1154, 2015
- 4 December 2014
- Published by Wiley in The Laryngoscope
- Vol. 125 (5) , 1149-1154
Safety and efficacy of multiuse botulinum toxin vials for intralaryngeal injection
Objectives/Hypothesis: Centers for Disease Control and Prevention guidelines maintain that single‐use vials cannot be used for multiple patients. Botox product labeling states that the reconstituted toxin should be used within 4 hours on a single patient based on concerns of reduced potency, contamination, and consequent infections. The purpose of this study was to determine the safety and efficacy of using single‐use vials in a multidose fashion.Study Design: Prospective study and cohort chart review.Methods: A multi‐institutional three‐part study was performed between May 2013 and October 2013: 1) a summation of subjects' recall of their past experiences (symptoms/response) with previous multidose Botox injections, 2) a prospective study of intralaryngeal injections, and 3) a chart review of injection responses in a subset of the cohort.Results: Seven hundred forty‐three subjects receiving 6,216 injections demonstrated zero infection‐related complications on retrospective chart review. One hundred seventy‐nine subjects recalled 24.0% overall adverse events, 10.6% redness, 7.3% pain and swelling at the injection site, and 0% fever. One hundred seventy‐four subjects prospectively reported 12.6% overall adverse events. The self‐reported efficacy rate of Botox injection was 96.6%.Conclusions: The low rates of adverse events following the use of Botox in a multipatient fashion are consistent with other percutaneous injections. No evidence of infection was found with multidose Botox use. Given the low incidence of side effects and high success rate, Botox can be used both safely and effectively in a multipatient fashion.Level of Evidence: 4 Laryngoscope, 125:1149–1154, 2015
- 1 November 2014
- Published by Elsevier in Journal of Voice
- Vol. 28 (6) , 711-715
Validation of a Telephone Screening Tool for Spasmodic Dysphonia and Vocal Fold Tremor
- 1 November 2014
- Published by Elsevier in Journal of Voice
- Vol. 28 (6) , 711-715
Validation of a Telephone Screening Tool for Spasmodic Dysphonia and Vocal Fold Tremor